AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
FUTURE PERSPECTIVES FOR THE DEVELOPMENT OF P-GLYCOPROTEIN MODULATORS
Authors: SANDOR V FOJO T BATES SE
Citation: V. Sandor et al., FUTURE PERSPECTIVES FOR THE DEVELOPMENT OF P-GLYCOPROTEIN MODULATORS, DRUG RESISTANCE UPDATES, 1(3), 1998, pp. 190-200
EFFECTS OF P53-EXPRESSING ADENOVIRUS ON THE CHEMOSENSITIVITY AND DIFFERENTIATION OF ANAPLASTIC THYROID-CANCER CELLS
Authors: BLAGOSKLONNY MV GIANNAKAKOU P WOJTOWICZ M ROMANOVA LY AIN KB BATES SE FOJO T
Citation: Mv. Blagosklonny et al., EFFECTS OF P53-EXPRESSING ADENOVIRUS ON THE CHEMOSENSITIVITY AND DIFFERENTIATION OF ANAPLASTIC THYROID-CANCER CELLS, The Journal of clinical endocrinology and metabolism, 83(7), 1998, pp. 2516-2522
GENETIC-POLYMORPHISM IN MDR-1 - A TOOL FOR EXAMINING ALLELIC EXPRESSION IN NORMAL-CELLS, UNSELECTED AND DRUG-SELECTED CELL-LINES, AND HUMANTUMORS
Authors: MICKLEY LA LEE JS WENG Z ZHAN ZR ALVAREZ M WILSON W BATES SE FOJO T
Citation: La. Mickley et al., GENETIC-POLYMORPHISM IN MDR-1 - A TOOL FOR EXAMINING ALLELIC EXPRESSION IN NORMAL-CELLS, UNSELECTED AND DRUG-SELECTED CELL-LINES, AND HUMANTUMORS, Blood, 91(5), 1998, pp. 1749-1756
IDENTIFICATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 PATHWAY INHIBITORS BY CORRELATION WITH GENE-EXPRESSION PATTERNS
Authors: WOSIKOWSKI K SCHUURHUIS D JOHNSON K PAULL KD MYERS TG WEINSTEIN JN BATES SE
Citation: K. Wosikowski et al., IDENTIFICATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 PATHWAY INHIBITORS BY CORRELATION WITH GENE-EXPRESSION PATTERNS, Journal of the National Cancer Institute, 89(20), 1997, pp. 1505-1515
DETECTION OF IN-VIVO P-GLYCOPROTEIN INHIBITION BY PSC-833 USING TC-99M SESTAMIBI
Authors: CHEN CC MEADOWS B REGIS J KALAFSKY G FOJO T CARRASQUILLO JA BATES SE
Citation: Cc. Chen et al., DETECTION OF IN-VIVO P-GLYCOPROTEIN INHIBITION BY PSC-833 USING TC-99M SESTAMIBI, Clinical cancer research, 3(4), 1997, pp. 545-552
ALTERED GENE-EXPRESSION IN DRUG-RESISTANT HUMAN BREAST-CANCER CELLS
Authors: WOSIKOWSKI K SCHUURHUIS D KOPS GJPL SACEDA M BATES SE
Citation: K. Wosikowski et al., ALTERED GENE-EXPRESSION IN DRUG-RESISTANT HUMAN BREAST-CANCER CELLS, Clinical cancer research, 3(12), 1997, pp. 2405-2414
THE ROLE OF MDR-1 IN REFRACTORY LYMPHOMA
Authors: SANDOR V WILSON W FOJO T BATES SE
Citation: V. Sandor et al., THE ROLE OF MDR-1 IN REFRACTORY LYMPHOMA, Leukemia & lymphoma, 28(1-2), 1997, pp. 23-31
REDUCED DRUG ACCUMULATION AND MULTIDRUG-RESISTANCE IN HUMAN BREAST-CANCER CELLS WITHOUT ASSOCIATED P-GLYCOPROTEIN OR MRP OVEREXPRESSION
Authors: LEE JS SCALA S MATSUMOTO Y DICKSTEIN B ROBEY R ZHAN ZR ALTENBERG G BATES SE
Citation: Js. Lee et al., REDUCED DRUG ACCUMULATION AND MULTIDRUG-RESISTANCE IN HUMAN BREAST-CANCER CELLS WITHOUT ASSOCIATED P-GLYCOPROTEIN OR MRP OVEREXPRESSION, Journal of cellular biochemistry, 65(4), 1997, pp. 513-526
AN INFORMATION-INTENSIVE APPROACH TO THE MOLECULAR PHARMACOLOGY OF CANCER
Authors: WEINSTEIN JN MYERS TG OCONNOR PM FRIEND SH FORNACE AJ KOHN KW FOJO T BATES SE RUBINSTEIN LV ANDERSON NL BUOLAMWINI JK VANOSDOL WW MONKS AP SCUDIERO DA SAUSVILLE EA ZAHAREVITZ DW BUNOW B VISWANADHAN VN JOHNSON GS WITTES RE PAULL KD
Citation: Jn. Weinstein et al., AN INFORMATION-INTENSIVE APPROACH TO THE MOLECULAR PHARMACOLOGY OF CANCER, Science, 275(5298), 1997, pp. 343-349
P-GLYCOPROTEIN SUBSTRATES AND ANTAGONISTS CLUSTER INTO 2 DISTINCT GROUPS
Authors: SCALA S AKHMED N RAO US PAULL K LAN LB DICKSTEIN B LEE JS ELGEMEIE GH STEIN WD BATES SE
Citation: S. Scala et al., P-GLYCOPROTEIN SUBSTRATES AND ANTAGONISTS CLUSTER INTO 2 DISTINCT GROUPS, Molecular pharmacology, 51(6), 1997, pp. 1024-1033
EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE IN REFRACTORY LYMPHOMA - QUANTITATION BY A VALIDATED POLYMERASE CHAIN-REACTION ASSAY
Authors: ZHAN ZR SANDOR VA GAMELIN E REGIS J DICKSTEIN B WILSON W FOJO AT BATES SE
Citation: Zr. Zhan et al., EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE IN REFRACTORY LYMPHOMA - QUANTITATION BY A VALIDATED POLYMERASE CHAIN-REACTION ASSAY, Blood, 89(10), 1997, pp. 3795-3800
CLINICAL REVERSAL OF MULTIDRUG-RESISTANCE
Authors: BATES SE WILSON WH FOJO AT ALVAREZ M ZHAN Z REGIS J ROBEY R HOSE C MONKS A KANG YK CHABNER B
Citation: Se. Bates et al., CLINICAL REVERSAL OF MULTIDRUG-RESISTANCE, Stem cells, 14(1), 1996, pp. 56-63
MECHANICAL-PROPERTIES OF NANOCRYSTALLINE COPPER PRODUCED BY SOLUTION-PHASE SYNTHESIS
Authors: SURYANARAYANAN R FREY CA SASTRY SML WALLER BE BATES SE BUHRO WE
Citation: R. Suryanarayanan et al., MECHANICAL-PROPERTIES OF NANOCRYSTALLINE COPPER PRODUCED BY SOLUTION-PHASE SYNTHESIS, Journal of materials research, 11(2), 1996, pp. 439-448
CHROMOSOMAL CHANGES AND PROGRESSIVE TUMORIGENESIS OF HUMAN BRONCHIAL EPITHELIAL-CELL LINES
Authors: OHNUKI Y REDDEL RR BATES SE LEHMAN TA LECHNER JF HARRIS CC
Citation: Y. Ohnuki et al., CHROMOSOMAL CHANGES AND PROGRESSIVE TUMORIGENESIS OF HUMAN BRONCHIAL EPITHELIAL-CELL LINES, Cancer genetics and cytogenetics, 92(2), 1996, pp. 99-110
BRAIN-DERIVED NEUROTROPHIC FACTOR PROTECTS NEUROBLASTOMA-CELLS FROM VINBLASTINE TOXICITY
Authors: SCALA S WOSIKOWSKI K GIANNAKAKOU P VALLE P BIEDLER JL SPENGLER BA LUCARELLI E BATES SE THIELE CJ
Citation: S. Scala et al., BRAIN-DERIVED NEUROTROPHIC FACTOR PROTECTS NEUROBLASTOMA-CELLS FROM VINBLASTINE TOXICITY, Cancer research, 56(16), 1996, pp. 3737-3742
METHODS TO DETECT P-GLYCOPROTEIN-ASSOCIATED MULTIDRUG-RESISTANCE IN PATIENTS TUMORS - CONSENSUS RECOMMENDATIONS
Authors: BECK WT GROGAN TM WILLMAN CL CORDONCARDO C PARHAM DM KUTTESCH JF ANDREEFF M BATES SE BERARD CW BOYETT JM BROPHY NA BROXTERMAN HJ CHAN HSL DALTON WS DIETEL M FOJO AT GASCOYNE RD HEAD D HOUGHTON PJ SRIVASTAVA DK LEHNERT M LEITH CP PAIETTA E PAVELIC ZP RIMSZA L RONINSON IB SIKIC BI TWENTYMAN PR WARNKE R WEINSTEIN R
Citation: Wt. Beck et al., METHODS TO DETECT P-GLYCOPROTEIN-ASSOCIATED MULTIDRUG-RESISTANCE IN PATIENTS TUMORS - CONSENSUS RECOMMENDATIONS, Cancer research, 56(13), 1996, pp. 3010-3020
STEROID-TRANSPORT, ACCUMULATION, AND ANTAGONISM OF P-GLYCOPROTEIN IN MULTIDRUG-RESISTANT CELLS
Authors: BARNES KM DICKSTEIN B CUTLER GB FOJO T BATES SE
Citation: Km. Barnes et al., STEROID-TRANSPORT, ACCUMULATION, AND ANTAGONISM OF P-GLYCOPROTEIN IN MULTIDRUG-RESISTANT CELLS, Biochemistry, 35(15), 1996, pp. 4820-4827
BRYOSTATIN-1 AFFECTS P-GLYCOPROTEIN PHOSPHORYLATION BUT NOT FUNCTION IN MULTIDRUG-RESISTANT HUMAN BREAST-CANCER CELLS
Authors: SCALA S DICKSTEIN B REGIS J SZALLASI Z BLUMBERG PM BATES SE
Citation: S. Scala et al., BRYOSTATIN-1 AFFECTS P-GLYCOPROTEIN PHOSPHORYLATION BUT NOT FUNCTION IN MULTIDRUG-RESISTANT HUMAN BREAST-CANCER CELLS, Clinical cancer research, 1(12), 1995, pp. 1581-1587
COEXPRESSION OF TGF-ALPHA, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND P-GLYCOPROTEIN IN NORMAL AND BENIGN DISEASED BREAST TISSUES
Authors: SCALA S SAEKI T LYNCH A SALOMON D MERINO MJ BATES SE
Citation: S. Scala et al., COEXPRESSION OF TGF-ALPHA, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND P-GLYCOPROTEIN IN NORMAL AND BENIGN DISEASED BREAST TISSUES, Diagnostic molecular pathology, 4(2), 1995, pp. 136-142
NORMAL P53 STATUS AND FUNCTION DESPITE THE DEVELOPMENT OF DRUG-RESISTANCE IN HUMAN BREAST-CANCER CELLS
Authors: WOSIKOWSKI K REGIS JT ROBEY RW ALVAREZ M BUTERS JTM GUDAS JM BATES SE
Citation: K. Wosikowski et al., NORMAL P53 STATUS AND FUNCTION DESPITE THE DEVELOPMENT OF DRUG-RESISTANCE IN HUMAN BREAST-CANCER CELLS, Cell growth & differentiation, 6(11), 1995, pp. 1395-1403
SYNTHESIS OF TITANIUM BORIDE (TIB)(2) NANOCRYSTALLITES BY SOLUTION-PHASE PROCESSING
Authors: BATES SE BUHRO WE FREY CA SASTRY SML KELTON KF
Citation: Se. Bates et al., SYNTHESIS OF TITANIUM BORIDE (TIB)(2) NANOCRYSTALLITES BY SOLUTION-PHASE PROCESSING, Journal of materials research, 10(10), 1995, pp. 2599-2612
PHASE-I AND PHARMACOKINETIC STUDY OF THE MULTIDRUG-RESISTANCE MODULATOR DEXVERAPAMIL WITH EPOCH CHEMOTHERAPY
Authors: WILSON WH JAMISDOW C BRYANT G BALIS FM KLECKER RW BATES SE CHABNER BA STEINBERG SM KOHLER DR WITTES RE
Citation: Wh. Wilson et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE MULTIDRUG-RESISTANCE MODULATOR DEXVERAPAMIL WITH EPOCH CHEMOTHERAPY, Journal of clinical oncology, 13(8), 1995, pp. 1985-1994
CONTROLLED TRIAL OF DEXVERAPAMIL, A MODULATOR OF MULTIDRUG-RESISTANCE, IN LYMPHOMAS REFRACTORY TO EPOCH CHEMOTHERAPY
Authors: WILSON WH BATES SE FOJO A BRYANT G ZHAN Z REGIS J WITTES RE JAFFE ES STEINBERG SM HERDT J CHABNER BA
Citation: Wh. Wilson et al., CONTROLLED TRIAL OF DEXVERAPAMIL, A MODULATOR OF MULTIDRUG-RESISTANCE, IN LYMPHOMAS REFRACTORY TO EPOCH CHEMOTHERAPY, Journal of clinical oncology, 13(8), 1995, pp. 1995-2004
A PILOT-STUDY OF AMIODARONE WITH INFUSIONAL DOXORUBICIN OR VINBLASTINE IN REFRACTORY BREAST-CANCER
Authors: BATES SE MEADOWS B GOLDSPIEL BR DENICOFF A LE TB TUCKER E STEINBERG SM ELWOOD LJ
Citation: Se. Bates et al., A PILOT-STUDY OF AMIODARONE WITH INFUSIONAL DOXORUBICIN OR VINBLASTINE IN REFRACTORY BREAST-CANCER, Cancer chemotherapy and pharmacology, 35(6), 1995, pp. 457-463
INCREASED RESISTANCE TO CYTOTOXIC AGENTS IN ZR75B HUMAN BREAST-CANCERCELLS TRANSFECTED WITH EPIDERMAL GROWTH-FACTOR RECEPTOR
Authors: DICKSTEIN BM WOSIKOWSKI K BATES SE
Citation: Bm. Dickstein et al., INCREASED RESISTANCE TO CYTOTOXIC AGENTS IN ZR75B HUMAN BREAST-CANCERCELLS TRANSFECTED WITH EPIDERMAL GROWTH-FACTOR RECEPTOR, Molecular and cellular endocrinology, 110(1-2), 1995, pp. 205-211
Risultati: 1-25 | 26-38